Peter Bühler

Peter joined Valneva as CFO in early 2022.

He has over 20 years of experience in the strategic and financial leadership of life science and technology companies.

Before joining Valneva, he served as CFO of Nasdaq-listed Swiss diagnostics company Quotient. He also served as Group CFO of Zaluvida AG and as Group CFO of Stallergenes Greer Plc, where he led a complex merger project to combine a French and U.S. company.

Prior to this, Peter held senior finance roles at Eli Lilly, Merck Serono and Logitech.

He is a Swiss Certified Accountant and holds an executive MBA.

Peter is a Swiss national, born in 1969.